Evidence map›Paper›PMID 37084629›Full record

ArticleJournal of geriatric oncology2023

Supervised learning applied to classifying fallers versus non-fallers among older adults with cancer.

Erika Ramsdale, Madhav Kunduru, Lisa Smith, Eva Culakova, Junchao Shen, Sixu Meng, Martin Zand, Ajay Anand

Registry-linked trialAbstract read
In one paragraph

Article in Journal of geriatric oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02054741 (A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02054741 nacompletednot on this map

A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer: Reducing Toxicity in Older Adults

TypeinterventionalSponsorSupriya MohileRan2014 to 2021Enrolled733ConditionsAdult Solid Neoplasm, Toxicity, LymphomaArmsComprehensive Geriatric Assessment, Quality-of-Life Assessment, Survey Administration
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Data, Models, and Visuals: How Data Science Methods Can Augment (Geriatric) Oncology Research.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erika RamsdaleJames P. Wilmot Cancer Center, University of Rochester Medical Center, NY, USA. Electronic address: erika_ramsdale@urmc.rochester.edu.
Madhav KunduruGoergen Institute for Data Science, University of Rochester, NY, USA.
Lisa SmithJames P. Wilmot Cancer Center, University of Rochester Medical Center, NY, USA.
Eva CulakovaJames P. Wilmot Cancer Center, University of Rochester Medical Center, NY, USA.
Junchao ShenDepartment of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Sixu MengCollege of Engineering, University of California, Berkeley, CA, USA.
Martin ZandClinical and Translational Science Institute, University of Rochester Medical Center, NY, USA.
Ajay AnandGoergen Institute for Data Science, University of Rochester, NY, USA.

Funding

Understanding Treatment Tolerability in Older Patients with CancerU01CA233167 · NCI · UNIVERSITY OF ROCHESTER · PI MOHILE, SUPRIYA G. · 2018 to 2023
$3.5M
Decreasing Polypharmacy in Older Adults with Curable CancersK08CA248721 · NCI · UNIVERSITY OF ROCHESTER · PI RAMSDALE, ERIKA E · 2020 to 2024
$1.2M
Polypharmacy, Potentially Inappropriate Medications, and Adverse Outcomes in Older Adults with Advanced Cancer Receiving ChemotherapyR03AG067977 · NIA · UNIVERSITY OF ROCHESTER · PI RAMSDALE, ERIKA E · 2020 to 2021
$308k
NCI NIH HHS K08 CA248721NCI NIH HHS U01 CA233167NIA NIH HHS R03 AG067977
6 · The paper itself

Abstract

introductionSupervised machine learning approaches are increasingly used to analyze clinical data, including in geriatric oncology. This study presents a machine learning approach to understand falls in a cohort of older adults with advanced cancer starting chemotherapy, including fall prediction and identification of contributing factors. MATERIALS AND

methodsThis secondary analysis of prospectively collected data from the GAP 70+ Trial (NCT02054741; PI: Mohile) enrolled patients aged ≥70 with advanced cancer and ≥ 1 geriatric assessment domain impairment who planned to start a new cancer treatment regimen. Of ≥2000 baseline variables ("features") collected, 73 were selected based on clinical judgment. Machine learning models to predict falls at three months were developed, optimized, and tested using data from 522 patients. A custom data preprocessing pipeline was implemented to prepare data for analysis. Both undersampling and oversampling techniques were applied to balance the outcome measure. Ensemble feature selection was applied to identify and select the most relevant features. Four models (logistic regression [LR], k-nearest neighbor [kNN], random forest [RF], and MultiLayer Perceptron [MLP]) were trained and subsequently tested on a holdout set. Receiver operating characteristic (ROC) curves were generated and area under the curve (AUC) was calculated for each model. SHapley Additive exPlanations (SHAP) values were utilized to further understand individual feature contributions to observed predictions.

resultsBased on the ensemble feature selection algorithm, the top eight features were selected for inclusion in the final models. Selected features aligned with clinical intuition and prior literature. The LR, kNN, and RF models performed equivalently well in predicting falls in the test set, with AUC values 0.66-0.67, and the MLP model showed AUC 0.75. Ensemble feature selection resulted in improved AUC values compared to using LASSO alone. SHAP values, a model-agnostic technique, revealed logical associations between selected features and model predictions. DISCUSSION: Machine learning techniques can augment hypothesis-driven research, including in older adults for whom randomized trial data are limited. Interpretable machine learning is particularly important, as understanding which features impact predictions is a critical aspect of decision-making and intervention. Clinicians should understand the philosophy, strengths, and limitations of a machine learning approach applied to patient data.

Indexed as

NeoplasmsAgedAlgorithmsHumansLogistic ModelsMachine LearningSupervised Machine Learning

Identifiers

PMID37084629
PMCPMC10174263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.